Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
Conditions: Percutaneous Coronary Intervention (PCI); Atrial Fibrillation (AF); Oral Anticoagulation; P2Y12 Inhibitor Interventions: Drug: P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel); Drug: Aspirin; Drug: DOAC Sponsors: Insel Gruppe AG, University Hospital Bern; Sahajanand Medical Technologies Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2023 Category: Research Source Type: clinical trials
Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms
Condition: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms Intervention: Sponsor: Methodist Health System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2023 Category: Research Source Type: clinical trials
